GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hypera SA (BSP:HYPE3) » Definitions » Other Net Income (Loss)

Hypera (BSP:HYPE3) Other Net Income (Loss) : R$-2 Mil (TTM As of Dec. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Hypera Other Net Income (Loss)?

Hypera's Other Net Income (Loss) for the three months ended in Dec. 2024 was R$-1 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 was R$-2 Mil.

Hypera's quarterly Other Net Income (Loss) declined from Jun. 2024 (R$1 Mil) to Sep. 2024 (R$0 Mil) and declined from Sep. 2024 (R$0 Mil) to Dec. 2024 (R$-1 Mil).

Hypera's annual Other Net Income (Loss) increased from Dec. 2022 (R$-8 Mil) to Dec. 2023 (R$-1 Mil) but then declined from Dec. 2023 (R$-1 Mil) to Dec. 2024 (R$-2 Mil).


Hypera Other Net Income (Loss) Historical Data

The historical data trend for Hypera's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hypera Other Net Income (Loss) Chart

Hypera Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.51 -287.44 -8.05 -0.56 -2.13

Hypera Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 -2.63 0.68 0.38 -0.55

Hypera Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hypera Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Hypera's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Hypera Business Description

Traded in Other Exchanges
Address
Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120
Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure. The Company's operating segments are Consumer Health, Branded Prescription, Similars e Generics, Skincare and Non-Retail Market.

Hypera Headlines

No Headlines